Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3579]

WCLC 2024: Perioperative nivolumab may provide meaningful improvement in event-free survival compared to only neoadjuvant nivolumab plus chemotherapy for resectable NSCLC

WCLC 2024: Perioperative nivolumab may provide meaningful improvement in event-free survival compared to only...

Researchers develop nanostructures to improve immune response to cancer

Researchers develop nanostructures to improve immune response to cancer

Researchers reveal key LAG3 mechanisms that could transform cancer immunotherapy

Researchers reveal key LAG3 mechanisms that could transform cancer immunotherapy

Scientists identify potential new immune system target to head off the spread of breast cancer cells

Scientists identify potential new immune system target to head off the spread of breast cancer cells

AI tool offers more accurate detection of immune-related adverse events in cancer patients

AI tool offers more accurate detection of immune-related adverse events in cancer patients

Scientists working to understand why men with prostate cancer are at higher risk of Alzheimer’s

Scientists working to understand why men with prostate cancer are at higher risk of Alzheimer’s

Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose

Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose

Innovations in cancer treatment through targeted bacterial vaccines

Innovations in cancer treatment through targeted bacterial vaccines

Common salt activates anti-tumor cells

Common salt activates anti-tumor cells

A hybrid arrowhead against immune disorders

A hybrid arrowhead against immune disorders

More from ecancer